Glenn F. Pierce

Canadian Hemophilia Society — Canada

Medicine · Health Sciences

78h-index23.5kcitations284works5.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemophilia Treatment and Research(137), Virus-based gene therapy research(67), Platelet Disorders and Treatments(52), CAR-T cell therapy research(43), Blood Coagulation and Thrombosis Mechanisms(40)

Publications284 total

Implementing Shared Decision-Making in Haemophilia Care: Best Practice Recommendations From a Western European Multi-Stakeholder Delphi Process.
PubMed·2026
Factor-VIII mimetic bispecific antibodies for the treatment of hemophilia A: an update.
PubMed·2026
A comprehensive care pathway of gene therapy for hemophilia based on current guideline documents and summary of product characteristics: communication from the ISTH SSC working group on gene therapy
Journal of Thrombosis and Haemostasis·2025Open Access
The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025
Haemophilia·2025· 3 citedOpen Access
The Critical Need to Consolidate All Gene Therapy Data in Haemophilia
Haemophilia·2025
AAV Gene Therapy in Severe Hemophilia B
New England Journal of Medicine·2025· 1 cited
Therapeutic innovations in hemophilia: the essential role of a positive reinvestment cycle
Blood Advances·2025· 1 citedOpen Access
Why is the uptake of gene therapy in hemophilia less than expected?
Research and Practice in Thrombosis and Haemostasis·2025· 2 citedOpen Access
Overview and Challenges of Distributed Decision Making in Resource Contested and Dynamic Environments
ACM Computing Surveys·2025· 1 citedOpen Access
Recommending defunct therapies is a safety risk for hemophilia.
PubMed·2025Open Access
Development of a novel gene editing lexicon for hemophilia: methodology and results
Research and Practice in Thrombosis and Haemostasis·2025· 1 citedOpen Access
Operationalising a Haemophilia Gene Editing Lexicon for Practical Use
Haemophilia·2025Open Access
Adeno-associated virus-based gene therapy for hemophilia–addressing the gaps
Research and Practice in Thrombosis and Haemostasis·2024· 8 citedOpen Access
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease
Haemophilia·2024· 4 citedOpen Access
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia—A Critical Appraisal
Haemophilia·2024· 6 citedOpen Access
Second gene therapy for hemophilia B approved: More answers or questions?
Molecular Therapy·2024· 4 citedOpen Access
Global prophylaxis trends in hemophilia: a macroeconomic analysis and its association with world development indicators
Expert Review of Hematology·2024· 6 cited
Site-Specific Insertion of Factor VIII Gene Results in Durable Factor VIII Expression in Nonhuman Primates
Blood·2024· 1 citedOpen Access
A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results
Haemophilia·2024· 4 citedOpen Access
Adeno-associated virus and hepatocytes: frenemies?
Blood Advances·2024Open Access
page 1 of 15Next →

Frequent Co-authors

Haiyan Jiang(14), Thomas A. Mustoe(11), Jürg M. Sommer(10), Arlen Thomason(8), Thomas F. Deuel(8), Margaret V. Ragni(7), Alvin Luk(6), Katherine A. High(6), Jennifer Dumont(6), Shangzhen Zhou(6), John Pasi(5), Neil C. Josephson(5), Tongyao Liu(5), Federico Mingozzi(4), Johnny Mahlangu(4), Jerry S. Powell(4), Jaya Goyal(4), J E Tarpley(4), Donna Yanagihara(4), Catherine S. Manno(3)